|
Clindamycin Phosphate In Dextrose 5% In Plastic ContainerDrug - Clindamycin Phosphate In Dextrose 5% In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Clindamycin Phosphate
Strength -
EQ 900MG BASE/100ML
Applicant -
BAXTER HLTHCARE
New Drug Application (NDA) Number -
050648
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 29, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Baxter Healthcare Corp
Clindamycin Phosphate In Dextrose 5% In Plastic Container
Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 900mg Base/100ml Injectable; Injection
Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% Eq 12mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% Eq 900mg Base/100ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 12mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 18mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 6mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 12mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 6mg Base/ml Injectable; Injection NewDrugInformation |